The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Introduction
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
Research works printed but not linked: 12
- Bennett, 2012, Evaluation of guideline recommendations on oral medications for type 2 diabetes mellitus, Ann Intern Med, 156, 27, 10.7326/0003-4819-156-1-201201030-00005 · DOI
- Alberti, 2007, International Diabetes Federation: a consensus on type 2 diabetes prevention, Diabet Med, 24, 451, 10.1111/j.1464-5491.2007.02157.x · DOI · Paper page
- McManus, 2012, Time for action: a Canadian proposal for primary prevention of type 2 diabetes, Can J Diabetes, 36, 44, 10.1016/j.jcjd.2012.04.006 · DOI
- 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 · DOI · Paper page
- Ettaro, 2004, Cost of illness studies in diabetes mellitus, Pharmacoeconomics, 22, 149, 10.2165/00019053-200422030-00002 · DOI · Paper page
- Gaede, 2008, Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes, Diabetes Care, 31, 1510, 10.2337/dc07-2452 · DOI
- Harris, 2005, Consensus, cost-effectiveness and clinical practice guidelines: author's response, Can J Diabetes, 29, 376
- 2007, Diabetes Care, 30, 2399, 10.2337/dc07-9925 · DOI · Paper page
- Sacks, 2012, Measurement of hemoglobin A1c: a new twist on the path to harmony, Diabetes Care, 35, 2674, 10.2337/dc12-1348 · DOI
- Weykamp, 2008, The IFCC reference measurement system for HbA1c: a 6-year progress report, Clin Chem, 54, 240, 10.1373/clinchem.2007.097402 · DOI · Paper page
- Leiter LA, Berard L, Bowering K, et al. Type 2 diabetes mellitus management in Canada: Is it improving? Can J Diabetes 2013: in press. · DOI
- McCormack, 2007, Adding “value” to clinical practice guidelines, Can Fam Physician, 53, 1326
Cited by
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
DiMeglio, L. A., Evans-Molina, C., & Oram, R. A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31320-5 · Cited by 1,561
Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective
Zhu, Y., & Zhang, C. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0699-x · Cited by 1,260
The IMAGE Study Group, Greaves, C. J., Sheppard, K. E., Abraham, C., Hardeman, W., Roden, M., Evans, P. H., & Schwarz, P. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-119 · Cited by 1,163
Glycemic Control and Excess Mortality in Type 1 Diabetes
Lind, M., Svensson, A.-M., Kosiborod, M., Gudbjörnsdottir, S., Pivodic, A., Wedel, H., Dahlqvist, S., Clements, M., & Rosengren, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408214 · Cited by 964
Metadata
- Authors
- Cheng, A. Y. Y.
- Venue
- Canadian Journal of Diabetes
- Publisher
- Elsevier BV
- Published
- 2013-04
- Volume
- 37
- Pages
- S1-S3
- ISSN
- 1499-2671 (ISSN-L)
- OpenAlex
- W4230159336
- Cited by
- 728
- References
- 3
- FWCI
- 66.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Introduction. https://app.cochat.ai/papers/10.1016/j.jcjd.2013.01.009
- The paper
- Cheng, A. Y. Y. (2013). Introduction. Canadian Journal of Diabetes. https://doi.org/10.1016/j.jcjd.2013.01.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
